1. Home
  2. RFL vs BHM Comparison

RFL vs BHM Comparison

Compare RFL & BHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • BHM
  • Stock Information
  • Founded
  • RFL 2017
  • BHM 2022
  • Country
  • RFL United States
  • BHM United States
  • Employees
  • RFL N/A
  • BHM N/A
  • Industry
  • RFL Real Estate
  • BHM Real Estate Investment Trusts
  • Sector
  • RFL Finance
  • BHM Real Estate
  • Exchange
  • RFL Nasdaq
  • BHM Nasdaq
  • Market Cap
  • RFL 54.4M
  • BHM 51.9M
  • IPO Year
  • RFL N/A
  • BHM N/A
  • Fundamental
  • Price
  • RFL $1.22
  • BHM $9.25
  • Analyst Decision
  • RFL
  • BHM Strong Buy
  • Analyst Count
  • RFL 0
  • BHM 1
  • Target Price
  • RFL N/A
  • BHM $15.00
  • AVG Volume (30 Days)
  • RFL 86.8K
  • BHM 6.0K
  • Earning Date
  • RFL 12-10-2025
  • BHM 01-01-0001
  • Dividend Yield
  • RFL N/A
  • BHM 5.27%
  • EPS Growth
  • RFL N/A
  • BHM N/A
  • EPS
  • RFL N/A
  • BHM N/A
  • Revenue
  • RFL $917,000.00
  • BHM $74,462,000.00
  • Revenue This Year
  • RFL N/A
  • BHM N/A
  • Revenue Next Year
  • RFL N/A
  • BHM N/A
  • P/E Ratio
  • RFL N/A
  • BHM N/A
  • Revenue Growth
  • RFL 43.96
  • BHM 27.95
  • 52 Week Low
  • RFL $1.19
  • BHM $8.72
  • 52 Week High
  • RFL $3.19
  • BHM $14.81
  • Technical
  • Relative Strength Index (RSI)
  • RFL 30.42
  • BHM 44.88
  • Support Level
  • RFL $1.19
  • BHM $8.72
  • Resistance Level
  • RFL $1.29
  • BHM $9.69
  • Average True Range (ATR)
  • RFL 0.06
  • BHM 0.34
  • MACD
  • RFL -0.00
  • BHM 0.09
  • Stochastic Oscillator
  • RFL 7.69
  • BHM 75.26

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About BHM Bluerock Homes Trust Inc.

Bluerock Homes Trust Inc owns and operates a portfolio of institutional residential properties including single-family homes, build-to-rent communities, and other residential communities located in attractive markets with a focus on the knowledge-economy and high-quality of life growth markets of the Sunbelt and Western United States. The company's principal objective is to generate attractive risk-adjusted returns on investments where it believes it can drive growth in funds from operations and net asset value by acquiring residential units, developing residential communities, and through value-add renovations. The Company is an externally managed REIT managed and advised by Bluerock Homes Manager, LLC.

Share on Social Networks: